The attendees will learn about the basis for the European screening recommendations from the European Union's Beating Cancer Plan and discuss the challenges and controversies of prostate cancer screening vs early detection, based on guidelines (EAU/AUA/NCCN). The session will review the role of imaging biomarkers in the detection and characterisation of prostate cancer, guidance of personalised treatment planning, prediction and assessment of response to therapy, and detection of disease recurrence. Furthermore, it will explore the emerging image-guided focal therapies as methods for personalised treatment of prostate cancer based on risk criteria and optimisation of oncologic and life quality outcomes.
Chairpersons' introduction
MR imaging in screening/organised testing in Europe
Novel multimodality imaging biomarkers
Image-guided therapies for prostate cancer